4//SEC Filing
RXi Pharmaceuticals Corp 4
Accession 0001181431-13-034208
$PHIOCIK 0001533040operating
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:06 PM ET
Size
5.3 KB
Accession
0001181431-13-034208
Insider Transaction Report
Form 4
Kontulis Caitlin
Secretary & Controller
Transactions
- Award
Stock Option (right to buy)
2013-06-07+300,000→ 300,000 totalExercise: $0.20Exp: 2023-06-07→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The award will vest 12.5% on the six month anniversary of the grant date, 12.5% on the one year anniversary of the grant date, and 25% on each of the second, third, and fourth anniversaries of the grant date thereafter.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001533040
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:06 PM ET
- Size
- 5.3 KB